权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Experimental Tobacco Marketplace: Forecasting the Health Equity of Novel Tax Proposals

实验性烟草市场：预测新税收提案的健康公平性

基本信息

批准号：
10522270
负责人：
Warren K Bickel
金额：
$ 69.49万
依托单位：
VIRGINIA POLYTECHNIC INST AND ST UNIV
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-15 至 2027-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10522270
关键词：
Address Affect Age Behavior Characteristics Cigarette Cigarette Smoker Complex Consumption Disease Electronic Nicotine Delivery Systems Entropy Experimental Models Goals Harm Reduction Health Health Policy Information Dissemination Laboratories Measures Methodology Methods Modeling Modified Risk Tobacco Product Nicotine Outcome Participant Pattern Policies Price Public Health Readiness Regulation Research Risk Sampling Science Smoker Smoking Socioeconomic Status Taxes Testing Tobacco Tobacco Dependence Tobacco use Translations United States Food and Drug Administration base behavioral economics cigarette smoking cigarillos combustible cigarette design experience health disparity health equity health inequalities health practice improved innovation low nicotine content cigarette low socioeconomic status novel outcome forecast parity polytobacco prospective recruit sex smoking cessation socioeconomic disparity socioeconomics tobacco abstinence tobacco control tobacco products tobacco regulation tobacco user

项目摘要

PROJECT SUMMARY/ABSTRACT The objective of this project is to forecast the impact of novel tobacco tax proposals in an evolving and complex tobacco marketplace, including how these proposals may interact with tobacco-related socioeconomic disparities and the introduction of low nicotine cigarettes (LNCs). Toward this end, we have developed the Experimental Tobacco Marketplace (ETM) to estimate, before implementation, the effects of potential policies on patterns of tobacco purchasing, including between-product substitution and poly-tobacco purchasing. The ETM places the mix of products, prices, and specific regulations under experimental control to provide estimates of policy impact under conditions that simulate “real-world” circumstances. Here we extend this method to examine the impact of four novel tax proposals that levy taxes across products based on either: (1) parity, (2) nicotine content, (3) potential for harm, or (4) the Food and Drug Administration designation as a modified-risk tobacco product. To accomplish these objectives, we will leverage our extensive experience in the behavioral economics of tobacco purchasing, in general, and with our unique and innovative ETM, in particular, to forecast the impact and health equity of these tax proposals. Specifically, Aim 1 will examine the effects of these four tax proposals on tobacco product purchasing in the ETM, including between-product substitution and poly-tobacco purchasing, in a laboratory-based sample of cigarette smokers. Aim 2 will examine the equity of these tax proposals by testing their effects in a nationally representative prospective sample of lower, medium and higher socioeconomic status smokers. Finally, Aim 3 will examine the impact of these tax proposals when LNCs are introduced to the market and when modeling a regulation that bans conventional cigarettes with higher nicotine content in a laboratory-based sample of cigarette smokers. Overall, this project is highly innovative and impactful because it prioritizes a clear translational path into public health policy and practice.

项目摘要/摘要该项目的目标是预测新的烟草税提案在一个不断发展和复杂的环境中的影响。烟草市场，包括这些建议如何与烟草相关的社会经济低尼古丁香烟（LNC）的引入。为此，我们制定了实验烟草市场（ETM），在实施前评估潜在政策的影响烟草购买模式，包括产品间替代和多种烟草购买。的 ETM将产品组合、价格和具体法规置于实验控制之下，以提供估计在模拟“现实世界”的情况下，政策的影响。在这里，我们将此方法扩展到研究四种新的税收建议的影响，这些建议基于以下两种原则对产品征税：（1）平价，（2）尼古丁含量，（3）潜在危害，或（4）食品和药物管理局指定为改良风险烟草制品。为了实现这些目标，我们将利用我们在行为方面的丰富经验，烟草购买的经济学，在一般情况下，并与我们独特的和创新的ETM，特别是预测这些税收提案的影响和健康公平性。具体而言，目标1将研究这四种税收的影响关于在ETM中购买烟草产品的建议，包括产品间替代和多种烟草购买，在实验室为基础的吸烟者样本。目标2将审查这些税收的公平性通过在全国代表性的低、中、高水平的前瞻性样本中测试其效果，吸烟者的社会经济地位。最后，目标3将研究这些税收建议的影响，当LNC 在市场上推出，并在模拟禁止尼古丁含量较高的传统卷烟的法规时，吸烟者的实验室样本中的含量。总的来说，这个项目具有很强的创新性和影响力因为它优先考虑将明确的转化路径纳入公共卫生政策和实践。